Clinical Study
Lobar Hepatocellular Carcinoma with Ipsilateral Portal Vein Tumor Thrombosis Treated with Yttrium-90 Glass Microsphere Radioembolization: Preliminary Results
| | Characteristics | Value |
| | Dead/alive () | 7/11 | | Response () CR/PR/SD/PD | 2/13/1/2 | | Objective response/disease control rate (%) | 83.3/88.9% | | Median (95% CI) time to progression (months) | 11.0 (8.0–16.5) | Median (95% CI) overall survival
(from date of treatment) | Not reached (9.0–∞) | | Downstaging to surgery or transplantation criteria () | 4/18 | | Overall survival at 6 months (% and 95% CI) | 88.5 ± 14.7 | | Overall survival at 1 year (% and 95% CI) | 70.3 ± 21.1 |
|
|
